| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | $58.05B | $57.18B | $47.08B | $25.70B | $26.64B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $11.92B | $10.94B | $10.69B | $10.80B | $13.31B |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | $35.66B | $35.59B | $25.43B | $6.09B | $5.42B |
| Tax Expense | $3.11B | $3.12B | $3.10B | $2.77B | $3.04B |
| Net Income | $6.93B | $6.99B | $7.20B | $5.70B | $5.46B |
| EPS (basic) | 2.0190 | 2.0090 | 2.0530 | 1.5990 | 1.4940 |
| EPS (diluted) | 1.9940 | 1.9170 | 1.9520 | 1.5240 | 1.3780 |
| Shares (diluted) | $3.69B | $3.90B | $3.89B | $3.89B | $4.12B |